Intensity Therapeutics INTS
NASDAQ INTS
$3.42 -0.23 (-6.28%)
As of: Sep 29, 2026 · 3:55 PM EDT

Intensity Therapeutics (INTS) Other Non-Current Liabilities (2022 - 2024)

Updated

Intensity Therapeutics' Other Non-Current Liabilities was $36,000 in Q1 2024, unchanged from the prior quarter.

Analysis

Intensity Therapeutics (INTS) Other Non-Current Liabilities (2022 - 2024) Analysis & Trends

From Q4 2022 onward, Intensity Therapeutics has reported Other Non-Current Liabilities for 4 quarters.

  • In earlier years, Other Non-Current Liabilities was $36,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Intensity Therapeutics 10.75 Mn 10.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 36,000.00
Dec 31, 2023 36,000.00
Sep 30, 2023 36,000.00
Dec 31, 2022 36,000.00
API Access

Intensity Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=INTS&period=max&api_key=YOUR_API_KEY